Up-Regulation of CXC Chemokine Receptor 4 Expression in Chronic Atrial Fibrillation Patients With Mitral Valve Disease May Be Attenuated by Renin–Angiotensin System Blockers

Journal of International Medical Research - United Kingdom
doi 10.1177/147323000903700419
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Association Between Renin-Angiotensin-Aldosterone System Blockers and Postoperative Atrial Fibrillation in Patients With Mild and Moderate Left Ventricular Dysfunction

Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology
2010English

Age and CHADS2 Score Predict the Effectiveness of Renin-Angiotensin System Blockers on Primary Prevention of Atrial Fibrillation

Scientific Reports
Multidisciplinary
2015English

Protection Against Death and Renal Failure by Renin-Angiotensin System Blockers in Patients With Diabetes and Kidney Disease

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2016English

Atrial Fibrillation in Patients With Chronic Kidney Disease

Jounal of arrhythmology
2020English

Comparative Expression Profiles of microRNA in Left and Right Atrial Appendages From Patients With Rheumatic Mitral Valve Disease Exhibiting Sinus Rhythm or Atrial Fibrillation

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2014English

Atrial Fibrillation in Patients With Mitral Regurgitation

Cardiologia Croatica
Cardiovascular MedicineCardiology
2018English

Dual Blockade of the Renin-Angiotensin System With Angiotensin Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARBs)

British Journal of Clinical Pharmacology
Pharmacology
2011English

Reduction of Microalbuminuria by Blockers: Beyond Renin-Angiotensin System Blockade

Hypertension
Internal Medicine
2005English

Evaluation of the New Onset Atrial Fibrillation in Patients With Mitral Valve Lesion and Left Atrial Enlargement

Annaly aritmologii
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy